This study compares the cost-effectiveness of long-acting monoclonal antibodies and maternal vaccines for RSV prevention in young children.
This study evaluates new RSV intervention strategies using mathematical modelling and economic analysis, highlighting the cost-effectiveness of seasonal programmes.
This study evaluates the cost-effectiveness of Nirsevimab intervention programmes for RSV prevention in England and Wales.
This study evaluates the epidemiological and cost-effectiveness impacts of mass paediatric influenza vaccination on existing elderly and risk-group programmes in England and Wales.